tetano
Editor, Senior Moderator
World J Pediatr
. 2024 Mar 20.
doi: 10.1007/s12519-023-00791-x. Online ahead of print. Severe acute respiratory syndrome coronavirus-2-related and imputable deaths in children: results from the French pediatric national registry
Marguerite Lockhart-Bouron[SUP] 1 [/SUP], Noémie Vanel[SUP] 2 [/SUP], Michael Levy[SUP] 3 4 [/SUP], Anaïs R Briant[SUP] 5 [/SUP], Etienne Javouhey[SUP] 6 [/SUP], Sophie Breinig[SUP] 7 [/SUP], Julia Dina[SUP] 8 9 [/SUP], Marion Caseris[SUP] 10 [/SUP], François Angoulvant[SUP] 11 [/SUP], Stéphane Leteurtre[SUP] 1 [/SUP], Morgan Recher[SUP] 1 [/SUP], David W Brossier[SUP] 12 13 14 15 [/SUP]
Affiliations
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for an important mortality rate worldwide. We aimed to evaluate the actual imputability of SARS-CoV-2 on the mortality rate associated with SARS-CoV-2-related illnesses in the pediatric intensive care unit (PICU). Secondary objectives were to identify risk factors for death.
Methods: This national multicenter comparative study comprised all patients under 18 years old with positive SARS-CoV-2 polymerase chain reactions (PCRs) [acute corona virus disease 2019 (COVID-19) or incidental SARS-CoV-2 infection] and/or pediatric inflammatory multisystem syndrome (PIMS) recorded in the French PICU registry (PICURe) between September 1, 2021, and August 31, 2022. Included patients were classified and compared according to their living status at the end of their PICU stay. Deceased patients were evaluated by four experts in the field of pediatric infectiology and/or pediatric intensive care. The imputability of SARS-CoV-2 as the cause of death was classified into four categories: certain, very probable, possible, or unlikely, and was defined by any of the first three categories.
Results: There were 948 patients included of which 43 died (4.5%). From this, 26 deaths (67%) could be attributed to SARS-CoV-2 infection, with an overall mortality rate of 2.8%. The imputability of death to SARS-CoV-2 was considered certain in only one case (0.1%). Deceased patients suffered more often from comorbidities, especially heart disease, neurological disorders, hematological disease, cancer, and obesity. None of the deceased patients were admitted for pediatric inflammatory multisystem syndrome (PIMS). Mortality risk factors were male gender, cardiac comorbidities, cancer, and acute respiratory distress syndrome.
Conclusions: SARS-CoV-2 mortality in the French pediatric population was low. Even though the imputability of SARS-CoV-2 on mortality was considered in almost two-thirds of cases, this imputability was considered certain in only one case.
Keywords: Death; Pediatric intensive care unit; SARS-CoV-2.
. 2024 Mar 20.
doi: 10.1007/s12519-023-00791-x. Online ahead of print. Severe acute respiratory syndrome coronavirus-2-related and imputable deaths in children: results from the French pediatric national registry
Marguerite Lockhart-Bouron[SUP] 1 [/SUP], Noémie Vanel[SUP] 2 [/SUP], Michael Levy[SUP] 3 4 [/SUP], Anaïs R Briant[SUP] 5 [/SUP], Etienne Javouhey[SUP] 6 [/SUP], Sophie Breinig[SUP] 7 [/SUP], Julia Dina[SUP] 8 9 [/SUP], Marion Caseris[SUP] 10 [/SUP], François Angoulvant[SUP] 11 [/SUP], Stéphane Leteurtre[SUP] 1 [/SUP], Morgan Recher[SUP] 1 [/SUP], David W Brossier[SUP] 12 13 14 15 [/SUP]
Affiliations
- PMID: 38506979
- DOI: 10.1007/s12519-023-00791-x
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for an important mortality rate worldwide. We aimed to evaluate the actual imputability of SARS-CoV-2 on the mortality rate associated with SARS-CoV-2-related illnesses in the pediatric intensive care unit (PICU). Secondary objectives were to identify risk factors for death.
Methods: This national multicenter comparative study comprised all patients under 18 years old with positive SARS-CoV-2 polymerase chain reactions (PCRs) [acute corona virus disease 2019 (COVID-19) or incidental SARS-CoV-2 infection] and/or pediatric inflammatory multisystem syndrome (PIMS) recorded in the French PICU registry (PICURe) between September 1, 2021, and August 31, 2022. Included patients were classified and compared according to their living status at the end of their PICU stay. Deceased patients were evaluated by four experts in the field of pediatric infectiology and/or pediatric intensive care. The imputability of SARS-CoV-2 as the cause of death was classified into four categories: certain, very probable, possible, or unlikely, and was defined by any of the first three categories.
Results: There were 948 patients included of which 43 died (4.5%). From this, 26 deaths (67%) could be attributed to SARS-CoV-2 infection, with an overall mortality rate of 2.8%. The imputability of death to SARS-CoV-2 was considered certain in only one case (0.1%). Deceased patients suffered more often from comorbidities, especially heart disease, neurological disorders, hematological disease, cancer, and obesity. None of the deceased patients were admitted for pediatric inflammatory multisystem syndrome (PIMS). Mortality risk factors were male gender, cardiac comorbidities, cancer, and acute respiratory distress syndrome.
Conclusions: SARS-CoV-2 mortality in the French pediatric population was low. Even though the imputability of SARS-CoV-2 on mortality was considered in almost two-thirds of cases, this imputability was considered certain in only one case.
Keywords: Death; Pediatric intensive care unit; SARS-CoV-2.